Condition
Metastatic Colorectal Cancer (mCRC) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Metastatic Colorectal Cancer (mCRC) clinical trials that are recruiting, at sites in 10 countries (most in Germany (2), Russia (1), Norway (1)). By phase: Phase 2 (2), Phase 3 (1), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 10Countries
Newest Metastatic Colorectal Cancer (mCRC) clinical trials
All recruiting trials (10)
-
Continuing cetuximab after first progression for metastatic colorectal cancer
This study will test whether keeping cetuximab while switching the chemotherapy backbone helps adults with RAS/BRAF wild‑type metastatic colorectal cancer whose disease progressed after first‑line anti‑EGFR therapy.
-
µCAN diagnostic to pick the best drugs for metastatic colorectal cancer
This will test whether the µCAN lab test can identify the best drugs for people with metastatic colorectal cancer who are about to start a new line of treatment.
-
Combining hydroxychloroquine with chemotherapy for advanced colorectal cancer
This study is testing if adding hydroxychloroquine to standard chemotherapy can help people with advanced colorectal cancer live longer and feel better.
-
Effects of combined exercise on quality of life for colorectal cancer patients undergoing chemotherapy
This study tests if an 18-week exercise program can improve the quality of life for colorectal cancer patients who are receiving chemotherapy.
-
Testing a new treatment for metastatic colorectal cancer
This study is testing a new treatment called arfolitixorin for people with metastatic colorectal cancer to see if it works better than the usual therapy.
-
Evaluating Fruquintinib for Metastatic Colorectal Cancer
This study is testing how well Fruquintinib works for people with metastatic colorectal cancer who have already tried other treatments, to see how it affects their survival and quality of life.
-
Registry for patients with advanced metastatic colorectal cancer
This study is collecting information from patients with advanced colorectal cancer who have tried different treatments to see how well they are doing and to help improve future care.
-
Screening for KRAS G12C mutations in metastatic colorectal cancer
This study is testing a new kit to find out if people with metastatic colorectal cancer have a specific mutation so they can join a trial looking at a new treatment combination.
-
Evaluating HNF4α srRNA for treating metastatic colorectal cancer
This study is testing a new treatment called HNF4α srRNA to see if it is safe and tolerable for people with advanced colorectal cancer that can't be surgically removed.
-
Combining PDS01ADC with targeted liver chemotherapy for certain cancers
This study is testing if a new cancer treatment that combines an immune booster with targeted liver chemotherapy can help people with certain advanced cancers feel better and live longer.
Related topics
Quick answers
How many Metastatic Colorectal Cancer (mCRC) clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in Germany (2 trials), Russia (1 trial), Norway (1 trial), United States (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.